Brief: Lexeo Therapeutics Files For Resale Of Up To 6.97 Mln Shares By Selling Stockholders
09/04/2024 15:04
April 9 (Reuters) - Lexeo Therapeutics Inc LXEO.O :
* LEXEO THERAPEUTICS INC FILES FOR RESALE OF UP TO 6.97
MILLION
SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING
Source text for Eikon: ID:n0001193125-24-090233
Further company coverage: LXEO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lexeo Therapeutics
See all newsBrief: Lexeo Therapeutics Enters Into Agreement To Acquire Mantle Therapeutics And Announces Multiple New Strategic Collaborations To Expand Leadership In Friedreich Ataxia
Brief: Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Lx2020
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
U.S. STOCKS ON THE MOVE-Datadog, Terawulf
Lexeo rises as co sets late-stage trial plan for gene therapy in rare heart disease